...
首页> 外文期刊>Cardiovascular Research >Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD(+/-) and human SCN5A-1795insD(+/-) iPSC-derived cardiomyocytes
【24h】

Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD(+/-) and human SCN5A-1795insD(+/-) iPSC-derived cardiomyocytes

机译:抗心律失常潜力在鼠SCN5A-1798-1798-1798-1798INSD(+/-)和人体SCN5A-1795INSD(+/-)IPSC衍生的心肌细胞中的抗心律失常潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Aims Selective inhibition of cardiac late sodium current (I-NaL) is an emerging target in the treatment of ventricular arrhythmias. We investigated the electrophysiological effects of GS-458967 (GS967), a potent, selective inhibitor of I-NaL, in an overlap syndrome model of both gain and loss of sodium channel function, comprising cardiomyocytes derived from both human SCN5A-1795insD(+/-) induced pluripotent stem cells (hiPSC-CMs) and mice carrying the homologous mutation Scn5a-1798insD(+/-).
机译:目的是对心脏晚期电流(I-NAL)的选择性抑制是治疗心律失常的新出现的靶标。 我们研究了GS-458967(GS967),I-NAL的效率选择性抑制剂的电生理学效应,其在钠通道功能的增益和丧失的重叠综合征模型中,包括衍生自人SCN5A-1795INSD的心肌细胞(+ / - )诱导多能干细胞(HIPSC-CM)和携带同源突变SCN5A-1798INSD(+/-)的小鼠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号